SCHEMBL19555100

SCHEMBL19555100

CC(C)C[C@H](N)C(=O)O[C@@H]1[C@@H](O)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H](CO)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD209 Q9NNX6 1/20 0.46
▸ LGALS8 O00214 3/20 0.44
▸ SELE P16581 1/20 0.40
▸ IGF2R P11717 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ PRKD3 O94806 1/20 0.39
▸ PRKCG P05129 1/20 0.39
▸ PRKCB P05771 1/20 0.39
▸ PRKCA P17252 1/20 0.39
▸ PRKCH P24723 1/20 0.39
▸ PRKCI P41743 1/20 0.39
▸ PRKCE Q02156 1/20 0.39
▸ PRKCQ Q04759 1/20 0.39
▸ PRKCZ Q05513 1/20 0.39
▸ PRKCD Q05655 1/20 0.39
▸ PRKD1 Q15139 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ GJA1 P17302 1/20 0.38
▸ GJB2 P29033 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17767394 0.86 LGALS8 (0.49) LGALS8SELEIGF2RMEN1KMT2A
Trehalose SCHEMBL19555099 0.86 SLC7A5 (0.50) CD209IGF2RMEN1KMT2APRKD3
SCHEMBL8373863 0.85 LGALS8 (0.48) LGALS8SELEIGF2RMEN1KMT2A
SCHEMBL12500790 0.81 MAPK1 (0.41) CD209LGALS8ALDH1A1
SCHEMBL7699917 0.80 LGALS8 (0.42) LGALS8SELEIGF2RMEN1KMT2A
SCHEMBL7699916 0.80 LGALS8 (0.42) LGALS8SELEIGF2RMEN1KMT2A
SCHEMBL1984503 0.79 LGALS8 (0.52) LGALS8SELEIGF2RMEN1KMT2A
Maltose SCHEMBL8141523 0.79 CD209 (0.51) CD209LGALS8IGF2RMEN1KMT2A
Trehalose SCHEMBL23716930 0.79 CD209 (0.44) CD209SELEIGF2RMEN1KMT2A
SCHEMBL17767393 0.78 IGF2R (0.44) LGALS8IGF2RMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452170-A1 DRY POWDER TREPROSTINIL FOR THE TREATMENT OF PULMONARY HYPERTENSION Liquidia Technologies, Inc. (US) 2019-03-13 — — EP disclosed
WO-2017192993-A1 DRY POWDER TREPROSTINIL FOR THE TREATMENT OF PULMONARY HYPERTENSION LIQUIDIA TECHNOLOGIES, INC. (US) 2017-11-09 — — WO disclosed
Send feedback